AWH logo

AWH Aspira Women's Health Inc.

NASDAQ Capital Market · Medical - Diagnostics & Research · Healthcare

$0.08
-0.02 (-15.90%)

Aspira Women's Health Inc., alongside its subsidiaries, specializes in the development and commercialization of diagnostic tools for gynecologic diseases across the United States. Their product portfolio includes tests such as OVA1, OVERA, and OVA1plus, designed to evaluate the risk of ovarian malignancy in women presenting with adnexal masses. Additionally, they provide ASPiRA GenetiX, a genetic …

Market Cap: $2.46Maspirawh.com

Price

No data yet.

Social Signal Score

50
5d
—
30d
—
60d
50
2 mentions
—
90d
50
2 mentions
—
news: 2

Analyst Ratings

5 analysts
Buyconsensus
Strong Buy 0Buy 3Hold 2Sell 0Strong Sell 0
Avg price target$3.3+3924.4%
Low $3.3Median $3.3High $3.3
Current Consensus

Revenue

$2.05M+228.41%
$623.0K$1.25M$1.87M$2.49M
Sep 2016Jun 2026

Analyst Estimates

FY2025
$-0.50
$-0.50–$-0.50
1 analysts
FY2026
$-0.26
$-0.26–$-0.26
1 analysts
FY2027
$0.00
$0.00–$0.00
0 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Nicolette Possemato
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
66
Beta
2.01
Country
US
Piotroski score
2 / 9 (Weak)
Altman Z-score
-168.99
aspirawh.com